Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Remifentanil Sedation for Stapedotomy
NCT06283836Completed
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in otosclerosis (2 arms), sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Primary endpoints: Patient satisfaction at 24 hours and Surgeon satisfaction. Started Mar 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
otosclerosis
Beyond the preview
Go deeper on NCT06283836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06283836.